(Q28282037)

Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull

21 January 2018

1 reference

Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results

21 January 2018

1 reference

Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation.

21 January 2018

1 reference

Repopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors

21 January 2018

1 reference

Tumor volume and local control probability: clinical data and radiobiological interpretations

21 January 2018

1 reference

The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography

21 January 2018

1 reference

The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix

21 January 2018

1 reference

Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia

21 January 2018

1 reference

Impact of adjuvant inhibition of vascular endothelial growth factor receptor tyrosine kinases on tumor growth delay and local tumor control after fractionated irradiation in human squamous cell carcinomas in nude mice

21 January 2018

1 reference

C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.

21 January 2018

1 reference

Incorporating biologic measurements (SF2, CFE) into a tumor control probability model increases their prognostic significance: a study in cervical carcinoma treated with radiation therapy

21 January 2018

1 reference

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

21 January 2018

1 reference

Successful therapy must eradicate cancer stem cells.

31 March 2020

1 reference

Tumour stem cells: the biological concept and its application in cancer treatment

31 March 2020

1 reference

Prospective identification of tumorigenic breast cancer cells

31 March 2020

1 reference

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

31 March 2020

1 reference

Stereotactic single-dose radiotherapy of stage I non–small-cell lung cancer (NSCLC)

31 March 2020

1 reference

Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study

31 March 2020

1 reference

Radiation oncology: a century of achievements.

31 March 2020

1 reference

IX. The use of X-Rays in Carcinoma

31 March 2020

1 reference

Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation

31 March 2020

1 reference

Multivariate determinants of radiocurability. I: Prediction of single fraction tumor control doses

31 March 2020

1 reference

In vivo radiation sensitivity of glioblastoma multiforme.

31 March 2020

1 reference

Radiation response of xenografts of a human squamous cell carcinoma and a glioblastoma multiforme: a progress report.

31 March 2020

1 reference

Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.

31 March 2020

1 reference

Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation.

31 March 2020

1 reference

Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial.

31 March 2020

1 reference

Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships

31 March 2020

1 reference

A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation.

31 March 2020

1 reference

Recovery from sublethal damage during fractionated irradiation of human FaDu SCC

31 March 2020

1 reference

Influence of treatment time on the response of rat rhabdomyosarcoma R1H to fractionated irradiation

31 March 2020

1 reference

Prospective identification of tumorigenic prostate cancer stem cells

31 March 2020

1 reference

Identification of human brain tumour initiating cells

31 March 2020

1 reference

A tumorigenic subpopulation with stem cell properties in melanomas

31 March 2020

1 reference

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

31 March 2020

1 reference

Identification and expansion of human colon-cancer-initiating cells

31 March 2020

1 reference

Tumor growth need not be driven by rare cancer stem cells

31 March 2020

1 reference

Identifying cancer stem cells in solid tumors: case not proven

31 March 2020

1 reference

Most C6 cells are cancer stem cells: evidence from clonal and population analyses

31 March 2020

1 reference

A perivascular niche for brain tumor stem cells

31 March 2020

1 reference

CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells

31 March 2020

1 reference

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

31 March 2020

1 reference

CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer

31 March 2020

1 reference

Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer.

31 March 2020

1 reference

Comment on "Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells"

31 March 2020

1 reference

Modeling the initiation and progression of human acute leukemia in mice

31 March 2020

1 reference

"Destemming" cancer stem cells

31 March 2020

1 reference

The relation between tumour lethal doses and the radiosensitivity of tumour cells

31 March 2020

1 reference

Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy.

31 March 2020

1 reference

Changes of cell proliferation characteristics in a rat rhabdomyosarcoma before and after X-irradiation

31 March 2020

1 reference

The effect of anaemia on the fraction of hypoxic cells in an experimental tumour

31 March 2020

1 reference

Survival curves for tumor cells irradiated in vivo

31 March 2020

1 reference

Tumor volume: a basic and specific response predictor in radiotherapy

31 March 2020

1 reference

Distribution of radiation sensitivities for human tumor cells of specific histological types: comparison of in vitro to in vivo data.

31 March 2020

1 reference

The radioresponsiveness of human tumours and the initial slope of the cell survival curve

31 March 2020

1 reference

Tumor cell radiosensitivity is a major determinant of tumor response to radiation

31 March 2020

1 reference

Influence of tumor cell and stroma sensitivity on tumor response to radiation

31 March 2020

1 reference

31 March 2020

The 5Rs of radiobiology

1 reference

Chemotherapy resistance of glioblastoma stem cells

31 March 2020

1 reference

Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells

31 March 2020

1 reference

Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma

31 March 2020

1 reference

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

31 March 2020

1 reference

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.

31 March 2020

1 reference

Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers

31 March 2020

1 reference

Tumour stem cells: facts, interpretation and consequences

31 March 2020

1 reference

Tumour stem cells: the relevance of predictive assays for tumour control after radiotherapy

31 March 2020

1 reference

Assessing the likelihood of severe side effects in radiotherapy

31 March 2020

1 reference

Gene profiling in squamous cell carcinoma of the head and neck

31 March 2020

1 reference

Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?

31 March 2020

1 reference

Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas.

31 March 2020

1 reference

Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy

31 March 2020

1 reference

Theragnostic imaging for radiation oncology: dose-painting by numbers

31 March 2020

1 reference

A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy

31 March 2020

1 reference

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

31 March 2020

1 reference

The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times

31 March 2020

1 reference

The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study.

31 March 2020

1 reference

The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis

31 March 2020

1 reference

Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix

31 March 2020

1 reference

Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study.

31 March 2020

1 reference

Cancerous stem cells can arise from pediatric brain tumors

31 March 2020

1 reference

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

31 March 2020

1 reference

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

31 March 2020

1 reference

Cancer stem cells in radiation resistance.

31 March 2020

1 reference

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

31 March 2020

1 reference

WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells

31 March 2020

1 reference

Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line

31 March 2020

1 reference

Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs

31 March 2020

1 reference

The role of apoptosis in cancer development and treatment response

31 March 2020

1 reference

Radiation resistance and stem-like cells in brain tumors.

31 March 2020

1 reference

Cancer Stem Cells and Radiotherapy: New Insights Into Tumor Radioresistance

31 March 2020

1 reference

The influence of oxygen on the radiosensitivity of mammalian tissues

31 March 2020

1 reference

The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy

31 March 2020

1 reference

Hypoxia in cancer: significance and impact on clinical outcome

31 March 2020

1 reference

Hypoxic radiosensitization: adored and ignored

31 March 2020

1 reference

Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation

31 March 2020

1 reference

HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth.

31 March 2020

1 reference

HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity

31 March 2020

1 reference

Hypoxia requires notch signaling to maintain the undifferentiated cell state

31 March 2020

1 reference

Influence of oxygen tension on CD133 phenotype in human glioma cell cultures.

31 March 2020

1 reference

Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice.

31 March 2020

1 reference

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality

31 March 2020

1 reference

beta1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury.

31 March 2020

1 reference

Stem cells and their niches

31 March 2020

1 reference

The stem-cell niche as an entity of action

31 March 2020

1 reference

Making a tumour's bed: glioblastoma stem cells and the vascular niche.

31 March 2020

1 reference

PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo

31 March 2020

1 reference

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

31 March 2020

1 reference

EGFR-TK inhibition before radiotherapy reduces tumour volume but does not improve local control: differential response of cancer stem cells and nontumourigenic cells?

31 March 2020

1 reference

Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: possible role for thrombosis

31 March 2020

1 reference

Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC.

31 March 2020

1 reference

PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neck

31 March 2020

1 reference